Skip to content
SCTXScribe Therapeutics, Inc.

Earnings

When Scribe Therapeutics, Inc. reports, what it reported each quarter, and how the stock took the results.

6 quarters. Mar 31, 2025 to Sep 30, 2026. USD.

Quarter by quarter

Q3 2026$1.64M−91.9% vs Q3 2025

All quarters

PeriodEndedAnnouncedFiledLagFormRevenueΔ yoyEPS dil.MoveSource trail
FY 2026
Q3 2026Sep 30, 2026Nov 12, 2026 · after-hoursNov 12, 202643 d10-Q$1.64M−91.9%-$0.68—
Q2 2026Jun 30, 2026Sep 2, 2026 · after-hoursSep 2, 202664 d10-Q$1.92M−60.8%-$2.620.6%
Q1 2026Mar 31, 2026————————
FY 2025
Q3 2025Sep 30, 2025————$20.11M—$0.00—
Q2 2025Jun 30, 2025————$4.90M—-$4.08—
Q1 2025Mar 31, 2025————————

Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Source filings

10-QNov 12, 2026458503
10-QSep 2, 2026380191

Provenance

ProvenanceData status and checks

Scribe Therapeutics, Inc. · CIK 1853921 · Engraved from SEC EDGAR